How to get more from Wegovy and increase weight loss

Step 1: Understand why your results may have stalled

There's a common misconception that a plateau means Wegovy has stopped working. It usually hasn't. What's happened is that your body's energy-regulation systems have partially adjusted to a lower weight, meaning you burn fewer calories at rest than you did before. That's biology, not a personal shortcoming.

The Wegovy treatment overview explains how semaglutide acts on GLP-1 receptors in the brain and gut to reduce appetite and slow gastric emptying. That mechanism doesn't simply switch off, but its relative effect on total intake can diminish over time if eating habits haven't changed alongside it. Recognising that the medicine is one part of a system, not the whole system, is the first step toward breaking through a plateau.

According to data from the STEP 1 trial, published in the New England Journal of Medicine, participants on 2.4mg semaglutide achieved an average body-weight reduction of around 15% over 68 weeks alongside lifestyle changes. The lifestyle element was not incidental, it was part of the trial design and part of Wegovy's licensed indication.

Step 2: Reach your highest clinically tolerated dose

Dose is the most direct lever a prescriber has. Wegovy follows a stepped titration: 0.25mg, then 0.5mg, 1.0mg, 1.7mg and 2.4mg, each step held for roughly four weeks to allow your system to settle. If you're still at an intermediate dose, there is good evidence that moving to a higher dose produces meaningfully greater weight loss, provided you tolerate it.

The MHRA also approved a 7.2mg maintenance dose in January 2026 and a dedicated single-dose 7.2mg pen in April 2026 for adults with a BMI of 30 or above. Trial data at that dose reported an average weight loss of around 20.7% over 72 weeks, narrowing the gap with tirzepatide's headline figures. Whether you'd be a candidate for 7.2mg is a conversation between you and your prescriber, it's not suitable for everyone and the titration still starts at 0.25mg, with each step up carefully managed to suit your individual response.

If side effects have been holding your dose back, tell your prescriber. Staying longer at a lower dose, adjusting when in the day you inject, and fine-tuning what you eat around injection day are all strategies worth discussing rather than enduring quietly. You can read more about how each Wegovy dose tier differs in practice.

Step 3: Align your diet with what the medicine is already doing

Wegovy reduces appetite, sometimes dramatically. That creates a risk people don't always anticipate: eating too little, particularly too little protein. When calorie intake falls sharply, the body loses fat and lean muscle together. Preserving muscle matters because muscle drives your resting metabolism. Eating enough protein (most UK clinical guidance suggests aiming for 1.2–1.6g per kilogram of body weight daily on a GLP-1 medicine, though your prescriber or a dietitian should set a personal target) helps keep that balance right.

Beyond protein, fibre-rich foods (vegetables, legumes, wholegrains) support gut health, slow digestion further, and help you feel satisfied on smaller portions. Hydration matters too: Wegovy can cause nausea and vomiting, and inadequate fluid intake compounds that risk, as the NHS semaglutide information page notes.

For practical pointers on five specific actions that support better results on Wegovy, our clinical team has written a dedicated resource covering diet, activity and injection technique together.

Step 4: Build activity into the treatment period intentionally

Physical activity does two things on a GLP-1 medicine. First, it burns energy directly. Second, and arguably more important over the long run, resistance-based activity (bodyweight exercises, resistance bands, weights) protects and builds muscle mass that might otherwise reduce as you lose weight. That protects your metabolic rate as the months go on.

You don't need a gym membership or a formal programme. Three sessions a week of 30–40 minutes of activity that challenges your muscles is the kind of starting point NHS guidance recommends alongside weight-management medicines. Results at the 2.4mg maintenance dose were achieved in clinical trials that included a supervised lifestyle component, the activity piece is part of how those outcomes were generated, not a bolt-on suggestion.

If you're considering how private treatment fits with your current plan or want to discuss your dose progress with a prescriber, you can start a free consultation with nume. A real clinician reads your answers the same day, not an automated filter.